reduces haemodynamic variations along with other complications. [1] [2] [3] [4] In 2000, Dr. Brain invented the ProSeal laryngeal mask airway with a double cuff and a double lumen which seperates the respiratory and gastrointestinal tract along with providing an effective seal, improved and adequate controlled ventilation which was a useful advancement in the field of anaesthesia. 5 So we hypothesized that ProSeal LMA can be used as an effective alternative to ETT in laparoscopic surgeries as it provides stable haemodynamics with adequate ventilation and minimal postoperative complications.
This study was conducted to compare the ProSeal LMA and the endotracheal tube in laparoscopic cholecystectomy under general anaesthesia with regards to intra-operative haemodynamic responses, the ease of insertion of device and nasogastric tube, adequacy of ventilation and also occurrence of any post-operative complications like cough, sore throat, laryngospasm and tracheal aspiration.
METHODS
This prospective randomized comparative study was conducted in the Department of Anesthesiology at our medical college's attached hospital after obtaining approval from the institutional ethical committee and patient's written and informed consent. Sixty adult patients were included of either sex belonging to (American Society of Anesthesiologists) ASA grade 1 or 2, aged 20-60 years, posted for elective laparoscopic cholecystectomies under general anaesthesia. Patients with anticipated difficult airway, obesity (body mass index>35kg/m 2 ), oropharyngeal pathology, cardiopulmonary disease, cervical spine fracture or instability or patients at increased risk of aspiration (gastrooesophageal reflux disease, hiatus hernia, and pregnant patients) were excluded from the study.
All the patients were allocated randomly into two groups of 30 each; using computer generated random number table and sequentially numbered opaque sealed envelopes; PLMA Group who underwent insertion of a ProSeal LMA (n=30) and ETT Group who underwent insertion of an Endotracheal tube (n=30).
All the patients were undergone routine preanaesthetic evaluation before the surgery and explained about the anaesthetic technique and perioperative course. They were kept nil per oral overnight. After arrival in the operation theatre, 18G intravenous (IV) cannula was secured and Ringer lactate solution started through it.
All standard monitors noninvasive blood pressure (NIBP), pulse oximeter (SpO 2 ), electrocardiogram (ECG), Capnography (EtCO 2 ) were attached and baseline parameters were recorded. Intravenous midazolam 0.02 mg/kg, glycopyrrolate 0.005 mg/kg, and fentanyl 1-2 μg/kg were administered 1-2 min before induction. After pre-oxygenation with 100% O 2 for 3-5 minutes, anaesthesia was induced with propofol 2-2.5 mg/kg till the loss of verbal commands. Neuromuscular blockade to facilitate placement of device was achieved by rocuronium 0.8 mg/kg intravenously. The patient was manually ventilated by facemask using intermittent positive pressure ventilation (IPPV) with 100% oxygen for 90 seconds. Following adequate paralysis, the corresponding airway was inserted in each group.
In PLMA group, size 3 or 4 ProSeal LMA (according to weight) was inserted and cuff inflated with 20-30 ml of air with standard technique. In ETT group, endotracheal intubation (with appropriate size endotracheal tube) was performed using direct laryngoscopy. The time interval between holding the airway device to confirmation of correct placement by bilateral air entry on chest auscultation was noted. Correct placement of the devices was confirmed by adequate bilateral chest movement on manual ventilation, bilateral equal air entry on chest auscultation, normal capnography waveforms and oxygen saturation more than 95%. Also nasogastric tube of appropriate size was inserted in all patients using lubricated jelly.
Anaesthesia was maintained with oxygen, nitrous oxide, halothane and rocuronium. A tidal volume of 8 ml/kg, respiratory rate of 12/min and I/E ratio of 1:2, EtCO 2 between 35 to 45 mmHg was maintained for adequate ventilation.
At the end of the procedure, anaesthetic agents were discontinued and patients were kept on 100% oxygen with PLMA or ETT in situ. Patients were reversed with intravenous neostigmine 0.05 mg/kg and glycopyrrolate 0.01 mg/kg. The patient was extubated or the device removed once the patient became fully awake and met all the criteria of recovery from neuromuscular blockade. The patients were monitored in the post-anaesthesia care unit. Any incidences of sore throat, cough or any other complications were noted.
The patients were observed for various parameters; Insertion characteristics (attempts or ease of insertion and time taken for insertion) of the PLMA or ETT and the nasogastric tube (NGT). The ease of insertion and attempt were graded as: Easy insertion -insertion at first attempt with no resistance; difficult insertion -insertion with resistance or at second attempt; failed insertioninsertion not possible.
Haemodynamic parameters (HR,SBP,DBP,MAP) were recorded: Preoperatively (baseline), at the time of insertion, at 1,2 and 5 mins after insertion of device, after achieving pneumoperitoneum, at 30 mins and during removal of devices. Oxygen saturation (SpO 2 ) and endtidal carbon dioxide (EtCO 2 ) were also recorded. 
Statistical analysis
The sample size was calculated to be 30 patients in each group showing a significant difference between the two groups with regard to different study parameters and based on previous studies, with type 1 error of 0.05 and a power of 0.9. Statistical analysis was done using ChiSquare test, Fisher's Exact test and Student's paired and unpaired t-test. Null hypothesis was assumed. Data were analyzed using the statistical software (SPSS version 17.0, Chicago, IL, USA). Data were expressed as Mean±SD and percentage. P value of >0.05 was considered to be statistically not significant, a P value of <0.05 was statistically significant and a P value of <0.001 was highly significant.
RESULTS
In present study, both the groups were comparable with respect to demographic profile i.e. age, weight and sex, (P>0.05). ASA grade and Mallampati grade were also comparable, (P>0.05) ( Figure 1 ).
The ProSeal LMA was inserted easily in the first attempt in 66.67% patients whereas 33.33% patients required a second attempt and the mean time of insertion of PLMA was 37.40±16.09 seconds however, in ETT group, intubation was successful in first attempt in 96.7% patients and 18.3% patients required a second attempt with mean time of intubation was 31.17±20.89 seconds.
Figure 1: Demographic data.
The mean time of device insertion was statistically not significant (P>0.05). However the mean time of insertion in ETT group was shorter as compared to PLMA group (Table 1) . Similarly, at removal and extubation, the heart rate and mean arterial pressure also increased significantly, P<0.05 whereas in the ETT group as compared to the PLMA group, whereas in PLMA group, these parameters remained comparable to baseline values, (P>0.05) ( Table  5 ).
Figure 6: Comparison of complications.
The incidence of cough was 6.7% and 10% while that of sore throat was 10% and 20% in group PLMA and ETT respectively. (Figure 2 ) The mean oxygen saturation (SpO 2 ) was also comparable in both the groups, (P>0.05). 
DISCUSSION
The achievement of smooth induction and recovery with stable intraoperative haemodynamics and minimal postoperative complications remains an important anaesthetic goal during general anaesthesia in laparoscopic surgeries. The laryngoscopy and tracheal intubation leads to haemodynamic pressor response due to oropharyngeal stimulation and may prove to be detrimental for the patients with low cardiac reserve. 1 The ProSeal LMA, a supraglottic airway device with its additional features has proven to be favourable particularly in these situations.
PLMA has an added advantage of reduced risk of gastric insufflation, regurgitation and aspiration of gastric contents and proved to be efficient in laparoscopic surgeries where increased intra-abdominal pressure created by pnemoperitoneum required higher peak airway pressures for adequate pulmonary ventilation. 1, 2, 6 So with above hypothesis, we conducted a prospective randomized study in 60 adult patients undergone laparoscopic cholecystectomies and compared the haemodynamic responses, the ease of insertion of device and nasogastric tube and any complications in both groups.
The 66.67% of patients had easy insertion of ProSeal LMA while 33.3% patients required a second attempt with mean time of insertion being 37.40±16.09 seconds while, in the ETT group, intubation was successful in first attempt in 96.7% patients and 18.3% patients required a second attempt and the mean time of intubation was 31.17±20.89 seconds. The duration of insertion of ProSeal and endotracheal tube was statistically not significant, (P>0.05) however the mean time of insertion in ETT group was shorter. Saraswat et al and Kannan et al also reported no significant difference between the insertion time of ProSeal and endotracheal tube which concurs with present study.
9,10 Usually anesthesiologist's have more experience and confidence in traditional direct laryngoscopy and endotracheal intubation as compared to other alternative devices and PLMA is not used so frequently even in routine practice in all institutions. So it needs expertise for successful placement of PLMA in first attempt and with lesser time. It is always hesitating to use an alternative device unless it is indicated in some particular situation. This may be the cause of longer mean insertion time of device in PLMA group as compared to ETT group in our study however this was statistically not significant.
In the PLMA group, nasogastric tube was inserted in all patients in the first attempt with mean time of insertion of 18.84±6.84 seconds. This was comparable with study done by Shroff et al who reported a mean insertion time of 14 seconds in the PLMA group. 7 Sharma et al also had a 100% first attempt success rate of nasogastric insertion with Proseal LMA however 50% patients had first attempt success rate, while 43.3% and 6.7% required second and third attempt respectively in the ETT group with a mean insertion time of 73.00±71.06 seconds which was significantly higher than the PLMA group (P value < 0.001). 8 This may be due to presence of additional gastric channel along with the length of ProSeal which may be helpful for insertion of nasogastric tube as endotracheal tube obliterates the passage of nasogastric tube while insertion.
The HR, SBP, DBP and MAP significantly increased from the baseline value at intubation that persisted till 5 minutes in the ETT group (P < 0.05). Similarly the rise in HR, SBP, DBP and MAP was observed at extubation, (P<0.05). However, the haemodynamic parameters remained comparable to the baseline values (P>0.05) after insertion of ProSeal and at its removal. Saraswat et al reported significant increase in heart rate and the mean arterial pressure 10 seconds after intubation that lasted till 3 minutes after intubation and also during the time of extubation in the ETT group. 9 Sharma B et al reported that there were no significant haemodynamic changes at 1 and 5 min after insertion of PLMA, (P<0.05). 3 Similarly Kannan S et al concluded in their study that SBP, DBP and MAP were lower in group PLMA at 1 and 2 min after insertion and its removal, (P<0.05). 10 Piper et al also reported higher mean arterial blood pressures after intubation than after insertion of PLMA, which was significant, (P<0.01). 11 Similarly, Patel et al reported that there was rise in heart rate both during insertion and extubation in ETT group as compare to ProSeal LMA group and this change was highly significant,(P<0.01) The findings of Shroff et al, Carron et al and Kannan et al also concurred with present findings. 7, 10, 12, 13 However, Lalwani et al and Dave et al found that heart rate was increased significantly in both ETT and PLMA group whereas in our study, HR is increased significantly in ETT group only. 14, 15 This haemodynamic pressor response may be attributed to the sympathetic stimulation during laryngoscopy and intubation and this is due to sympathoadrenal response to tracheal intubation arises from stimulation of the pharyngeal wall and supraglottic region by tissue tension induced by laryngoscopy. This is mediated via vagal and glossopharyngeal afferents. The reflex circulatory response is seen with an increase in the plasma catecholamine levels after laryngoscopy. 13 Among the catecholamine's, noradrenaline levels show a greater surge after laryngoscopy and intubation.
This transient pressor response to laryngoscopy and tracheal intubation like hypertension and tachycardia is of not much significance in healthy patients but it may prove to be detrimental in patients with low cardiac reserve like myocardial insufficiency, hypertension or cerebrovascular disease. 2 The catecholamine's secreted due to stress response may increase heart rate and myocardial oxygen demand or consumption significantly which may lead to cardiac arrhythmias and myocardial ischemia.
The ProSeal LMA is a supraglottic airway device which does not require laryngoscopy and visualization of vocal cords for insertion so this makes the placement of ProSeal LMA less stimulating and easier than endotracheal intubation and therefore it provokes a lesser sympathetic response while its insertion as compared to ETT. The attenuation of the pressor response is due to diminished catecholamine release and lower cortisol levels after insertion of the ProSeal LMA. 2, 13, 16 The PLMA forms effective seal around the glottis opening which provides adequate ventilation and oxygenation along with CO 2 insufflation and pnemoperitoneum in reverse trendelenburg position without any significant gastric distension and pulmonary aspiration. Maltby et al also reported that both of the devices have equal effectiveness in terms of adequate ventilation and oxygenation in their study groups. 6 The PLMA has an additional feature of gastric drainage channel and higher sealing pressures which may protect against regurgitation and gastric aspiration. 16 The incidence of cough and sore throat was comparatively more in the ETT group than in the PLMA group. Saraswat et al and Maltby et al also reported a higher incidence of cough and sore throat after intubation in ETT group. 6, 9 Lim et al and Carron et al also reported that there was a significant incidence of cough after extubation as compared after removal of PLMA. 13 The lower incidence of cough and sore throat with ProSeal LMA could be due to the fact that it exerts less mucosal pressure and does not hamper the pharyngeal perfusion pressures. 5 The cuff of PLMA is less stimulating to pharyngeal mucosa as compared to ETT cuff in trachea which may be the cause of reduced incidence of postoperative nausea and vomiting also in these patients. 16 
Limitations
We were not able to make significant differences between two devices to secure an airway particularly in laparoscopic surgeries as we could not reveal that one device is far superior to the other device in terms of different parameters we have studied, this may be due to smaller sample size of our study. So it might be possible that further studies with larger sample size would make significant differences between the two techniques and the results could be better appreciated.
CONCLUSION
Present study concluded that the ProSeal LMA provides a reliable and secured airway with stable intraoperative haemodynamics and lesser postoperative complications so can be effectively used as an alternative to endotracheal tube in elective laparoscopic surgeries under general anaesthesia. However, PLMA requires expertise for its easier insertion and placement.
